MEREO BIOPHARMA GROUP PLC (MREO) Total liabilities 2022–2025
MEREO BIOPHARMA GROUP PLC (MREO) total liabilities at each fiscal year-end, per SEC filings.
$5.0MFY2025 · since FY2022: $26.0M → $5.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $5.0M | -67.6% |
| FY2024 | $15.4M | -3.4% |
| FY2023 | $16.0M | -38.6% |
| FY2022 | $26.0M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice